FDA Inspection 1265385 — Community Blood Center Of Greater Kansas City

Community Blood Center Of Greater Kansas City — FEI 1972933

The FDA completed an inspection of Community Blood Center Of Greater Kansas City on March 7, 2025 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 7, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)